Omada Health, Inc. (OMDA)
NASDAQ: OMDA · Real-Time Price · USD
19.02
-0.44 (-2.26%)
At close: Aug 8, 2025, 4:00 PM
19.40
+0.38 (2.00%)
After-hours: Aug 8, 2025, 5:35 PM EDT
Omada Health Stock Forecast
Stock Price Forecast
The 6 analysts that cover Omada Health stock have a consensus rating of "Strong Buy" and an average price target of $25, which forecasts a 31.44% increase in the stock price over the next year. The lowest target is $20 and the highest is $29.
Price Target: $25 (+31.44%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Omada Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 |
|---|---|---|
| Strong Buy | 3 | 3 |
| Buy | 3 | 3 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $27 → $28 | Strong Buy | Maintains | $27 → $28 | +47.21% | Aug 8, 2025 |
| Barclays | Barclays | Buy Maintains $21 → $24 | Buy | Maintains | $21 → $24 | +26.18% | Aug 8, 2025 |
| Needham | Needham | Strong Buy Maintains $23 → $24 | Strong Buy | Maintains | $23 → $24 | +26.18% | Aug 8, 2025 |
| JP Morgan | JP Morgan | Buy Initiates $20 | Buy | Initiates | $20 | +5.15% | Jul 1, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $25 | Buy | Initiates | $25 | +31.44% | Jul 1, 2025 |
Financial Forecast
Revenue This Year
226.28M
from 169.80M
Increased by 33.26%
Revenue Next Year
271.90M
from 226.28M
Increased by 20.16%
EPS This Year
-0.58
from -6.10
EPS Next Year
-0.24
from -0.58
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 235.3M | 287.0M | 337.6M |
| Avg | 226.3M | 271.9M | 326.8M |
| Low | 216.2M | 257.7M | 310.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 38.6% | 26.8% | 24.2% |
| Avg | 33.3% | 20.2% | 20.2% |
| Low | 27.3% | 13.9% | 14.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.38 | -0.12 | 0.13 |
| Avg | -0.58 | -0.24 | 0.00 |
| Low | -1.14 | -0.44 | -0.22 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.